133 related articles for article (PubMed ID: 36437216)
1. Health outcomes associated with patterns of substance use disorders among patients with type 2 diabetes and hypertension: Electronic health record findings.
Khan MTF; Lewis D; Kaelber DC; Winhusen TJ
Prim Care Diabetes; 2023 Feb; 17(1):43-47. PubMed ID: 36437216
[TBL] [Abstract][Full Text] [Related]
2. Medical complications associated with substance use disorders in patients with type 2 diabetes and hypertension: electronic health record findings.
Winhusen T; Theobald J; Kaelber DC; Lewis D
Addiction; 2019 Aug; 114(8):1462-1470. PubMed ID: 30851217
[TBL] [Abstract][Full Text] [Related]
3. Increased Morbidity and Mortality in Hypertensive Patients With Substance Use Disorders: Electronic Health Record Findings.
Winhusen T; Theobald J; Kaelber DC; Lewis D
J Stud Alcohol Drugs; 2020 Jul; 81(4):471-478. PubMed ID: 32800083
[TBL] [Abstract][Full Text] [Related]
4. Regular cannabis use, with and without tobacco co-use, is associated with respiratory disease.
Winhusen T; Theobald J; Kaelber DC; Lewis D
Drug Alcohol Depend; 2019 Nov; 204():107557. PubMed ID: 31557578
[TBL] [Abstract][Full Text] [Related]
5. The association between regular cannabis use, with and without tobacco co-use, and adverse cardiovascular outcomes: cannabis may have a greater impact in non-tobacco smokers.
Winhusen T; Theobald J; Kaelber DC; Lewis D
Am J Drug Alcohol Abuse; 2020 Jul; 46(4):454-461. PubMed ID: 31743053
[TBL] [Abstract][Full Text] [Related]
6. Functional and structural social support, substance use and sexual orientation from a nationally representative sample of US adults.
Kahle EM; Veliz P; McCabe SE; Boyd CJ
Addiction; 2020 Mar; 115(3):546-558. PubMed ID: 31599027
[TBL] [Abstract][Full Text] [Related]
7. The association between regular cocaine use, with and without tobacco co-use, and adverse cardiovascular and respiratory outcomes.
Winhusen T; Theobald J; Kaelber DC; Lewis D
Drug Alcohol Depend; 2020 Sep; 214():108136. PubMed ID: 32623147
[TBL] [Abstract][Full Text] [Related]
8. Substance use and mental diagnoses among adults with and without type 2 diabetes: Results from electronic health records data.
Wu LT; Ghitza UE; Batch BC; Pencina MJ; Rojas LF; Goldstein BA; Schibler T; Dunham AA; Rusincovitch S; Brady KT
Drug Alcohol Depend; 2015 Nov; 156():162-169. PubMed ID: 26392231
[TBL] [Abstract][Full Text] [Related]
9. COVID-19 risk and outcomes in patients with substance use disorders: analyses from electronic health records in the United States.
Wang QQ; Kaelber DC; Xu R; Volkow ND
Mol Psychiatry; 2021 Jan; 26(1):30-39. PubMed ID: 32929211
[TBL] [Abstract][Full Text] [Related]
10. Discrimination, Sexual Orientation Discrimination, and Severity of Tobacco Use Disorder in the United States: Results From the National Epidemiologic Survey on Alcohol and Related Conditions-III.
Kcomt L; Evans-Polce RJ; Engstrom CW; West BT; McCabe SE
Nicotine Tob Res; 2021 May; 23(6):920-930. PubMed ID: 32996575
[TBL] [Abstract][Full Text] [Related]
11. Comorbid Cannabis and Tobacco Use Disorders in Hospitalized Patients with Psychotic-Spectrum Disorders.
Reeves LE; Gaudiano BA; Metrik J; Guzman Holst C; Morena A; Sydnor VJ; Weinstock LM; Epstein-Lubow G
J Dual Diagn; 2018; 14(3):171-180. PubMed ID: 30265850
[TBL] [Abstract][Full Text] [Related]
12. Adoption of Electronic Health Record Among Substance Use Disorder Treatment Programs: Nationwide Cross-Sectional Survey Study.
Frimpong JA; Liu X; Liu L; Zhang R
J Med Internet Res; 2023 Dec; 25():e45238. PubMed ID: 38096006
[TBL] [Abstract][Full Text] [Related]
13. Impact of implementing a tobacco and recreational nicotine-free policy and enhanced treatments on programmatic and patient-level outcomes within a residential substance use disorder treatment program.
Hemmy Asamsama O; Miller SC; Silvestri MM; Bonanno C; Krondilou K
J Subst Abuse Treat; 2019 Dec; 107():44-49. PubMed ID: 31757264
[TBL] [Abstract][Full Text] [Related]
14. National rates and trends of tobacco and substance use disorders among atrial fibrillation hospitalizations.
Doshi R; Dave M; Majmundar M; Kumar A; Adalja D; Shariff M; Desai R; Ziaeian B; Vallabhajosyula S
Heart Lung; 2021; 50(2):244-251. PubMed ID: 33359929
[TBL] [Abstract][Full Text] [Related]
15. Severity of Alcohol, Tobacco, and Drug Use Disorders Among Sexual Minority Individuals and Their "Not Sure" Counterparts.
Boyd CJ; Veliz PT; Stephenson R; Hughes TL; McCabe SE
LGBT Health; 2019 Jan; 6(1):15-22. PubMed ID: 30638419
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and factors associated with potential substance use disorders among police officers in urban Tanzania: a cross-sectional study.
Ndumwa HP; Njiro BJ; Francis JM; Kawala T; Msenga CJ; Matola E; Mhonda J; Corbin H; Ubuguyu O; Likindikoki S
BMC Psychiatry; 2023 Mar; 23(1):175. PubMed ID: 36927411
[TBL] [Abstract][Full Text] [Related]
17. E-Cigarette Use, Polytobacco Use, and Longitudinal Changes in Tobacco and Substance Use Disorder Symptoms Among U.S. Adolescents.
Veliz P; Eisman A; McCabe SE; Evans-Polce R; McCabe VV; Boyd CJ
J Adolesc Health; 2020 Jan; 66(1):18-26. PubMed ID: 31395513
[TBL] [Abstract][Full Text] [Related]
18. Correlates of Concurrent Morbid Obesity and Tobacco Use Disorder Nationally in the Veterans Health Administration.
Roberts W; Rosenheck RA
J Dual Diagn; 2020 Oct; 16(4):373-381. PubMed ID: 32866073
[TBL] [Abstract][Full Text] [Related]
19. Examining the relationship of concurrent obesity and tobacco use disorder on the development of substance use disorders and psychiatric conditions: Findings from the NESARC-III.
Fields LJ; Roberts W; Schwing I; McCoy M; Verplaetse TL; Peltier MR; Carretta RF; Zakiniaeiz Y; Rosenheck R; McKee SA
Drug Alcohol Depend Rep; 2023 Jun; 7():100162. PubMed ID: 37159814
[TBL] [Abstract][Full Text] [Related]
20. Substance Use Disorders Among Veterans in a Nationally Representative Sample: Prevalence and Associated Functioning and Treatment Utilization.
Boden MT; Hoggatt KJ
J Stud Alcohol Drugs; 2018 Nov; 79(6):853-861. PubMed ID: 30573015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
